Key considerations for protein targets: Use ideal body weight (IBW) or adjusted body weight for calculations, not current weight in patients with obesity Distribute protein across meals rather than concentrating in one sitting Monitor for signs of inadequate intake: fatigue, weakness, hair loss, or poor wound healing Reassess needs every 36 months as weight changes Consult with a registered dietitian for personalized recommendations GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists exert their appetite-suppressing effects through multiple mechanisms
PlexusDx recommends contacting Poison Control (1-800-222-1222) or seeking emergency care if symptoms become severe rather than waiting to see if they resolve
J Biol Chem 236:15341543 Turrens JF, Alexandre A, Lehninger AL (1985) Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria
Critics of AGs argue they reduce generic competition by eroding the financial incentive for Paragraph IV challenges, effectively discouraging future patent challenges across the industry
Over several years of follow-up, about 8.8 percent experienced a fragility fracture